A Study to Assess the Safety and Efficacy of ASP1941 in Combination With α-glucosidase Inhibitor in Type 2 Diabetic Patients

• Status: Completed
• Trial end date: 2012-05-25

Summary

This study is to evaluate long-term safety and efficacy after concomitant administration of ASP1941 and α-glucosidase inhibitor in Japanese patients with type 2 diabetes mellitus.

• Phase: Phase 3

Details

• Lead Sponsor: Astellas Pharma Inc
• Treatments: Acarbose; Glycoside Hydrolase Inhibitors; Ipragliflozin; Miglitol; Voglibose